Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
The Challenge: A new United States-based biopharma working on its first cell therapy-based treatment had expanded the scope of their trial and extended its patient pool to include a patient in Beijing, China.
Download this case study to learn how they addressed the challenges of:
- Identifying a packaging / shipper solution
- Navigating the regulatory environment for product import
- Providing final mile white glove delivery service